Catalytic scavengers of organophosphates to potentiate butyrylcholinesterase (hBChE) as a catalytic bioscavenger and methods for making and using them
申请人:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US10172831B2
公开(公告)日:2019-01-08
Provided are N-alkyl imidazole 2-aldoximes, including cationic imidazolium and uncharged tertiary imidazole aldoximes, and compositions and methods for making and using them, including methods for reactivating human butyrylcholinesterase (hBChE) or acetylcholinesterase (hAChE) inhibited by organophosphate (OP). By administration of a composition of the invention, the inactive or conjugated hBChE-OP or hAChE-OP is reactivated and the catalytic cycle of turnover and inactivation of the OP is completed; and in alternative embodiments, secondary mechanisms of reversible protection of hBChE and hAChE from irreversible inactivation by OPs and reactivation of tissue AChE also contribute to overall efficacy.
本发明提供了N-烷基咪唑2-醛肟,包括阳离子咪唑鎓和不带电的叔咪唑醛肟,以及制造和使用它们的组合物和方法,包括重新激活被有机磷(OP)抑制的人丁酰胆碱酯酶(hBChE)或乙酰胆碱酯酶(hAChE)的方法。通过施用本发明的组合物,无活性或共轭的 hBChE-OP 或 hAChE-OP 被重新激活,OP 的周转和失活催化循环完成;在另一个实施方案中,可逆保护 hBChE 和 hAChE 免受 OP 的不可逆失活以及重新激活组织 AChE 的次级机制也有助于提高整体疗效。